Albany Molecular Research (AMRI) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
AMRI Announces First Quarter 2015 Results
May 5, 2015 7:30 AM EDTALBANY, N.Y., May 5, 2015 /PRNewswire/ --Â AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2015.
Highlights:
First quarter contract revenue of $75.1 million, up 47% from 2014 First quarter royalties of $6.7 million, down 19% from 2014 First quarter adjusted diluted EPS of $0.20 up 25% from $0.16 in 2014, including a $0.03 decrease in EPS from royalties in the current quarter Completed the acquisitions of SSCI/West Lafayette, Ind. and Glasgow UK businesses, broadening our capabilities in analytical and drug product development services... MoreAMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
May 1, 2015 8:00 AM EDTALBANY, N.Y., May 1, 2015 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference on Wednesday, May 13, 2015 at 4:20 p.m. ET.
A live audio webcast of the presentation can be... More
